Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis

Rheumatology

Volumn 47, Issue 5, 2008, Pages 665-669

  Galarraga, B ^a   Ho, M ^a   Youssef, H M ^b   Hill, A ^a   McMahon, H ^a   Hall, C ^b   Ogston, S ^c   Nuki, G ^b   Belch, J J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Fish oil; n 3 fatty acids; NSAIDs; RA

Indexed keywords

COD LIVER OIL; DICLOFENAC; ESSENTIAL FATTY ACID; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CHI-SQUARE DISTRIBUTION; COD LIVER OIL; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN; VITAMINS;

EID: 42949096871     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken024     Document Type: Article

References (22)

1. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980;208:401-6.
2. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495-505.
3. Belch JJ, Hill A. Evening,primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 2000;71 (1 Suppl):352S-6S.
4. Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH. Omega-3 fatty acids in rheumatoid arthritis: An overview. Semin Arthritis Rheum 1998;27:366-70.
5. James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997;27:85-97.
6. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum 1994;37:824-9.
7. Lau CS, Morley KD, Belch JJ. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis-a double-blind placebo controlled study. Br J Rheumatol 1993;32:982-9.
8. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand J Rheumatol 1992;21:178-85.
9. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum 1988;31:315-24.
10. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria for rheumatoid arthritis. J Am Med Assoc 1949;140:659-66.
11. Hagglund KJ, Roth DL, Haley WE, Alarcon GS. Discriminant and convergent validity of self-report measures of affective distress in patients with rheumatoid arthritis. J Rheumatol 1989;16:1428-32.
12. Bland M. An introduction to medical statistics, 3rd edn. Oxford: Oxford University Press, 2000.
13. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001;120:594-606.
14. Aletaha D, Smolen JS. Advances in anti-inflammatory therapy, Acta Med Austriaca 2002;29:1-6.
15. DeMaria AN. Relative dsk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 2002;89(6 Suppl 1):33-8.
16. Joint meeting of the arthritis advisory committee and the drug safety and risk management advisory committee of the US food and drug administration; February 16-18, 2005. 2006.
17. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis. Br Med J 2005;330:1366.
18. Soeken KL, Miller SA, Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: A systematic review. Rheumatology 2003;42:652-9.
19. Stamp LK, James MJ, Cleland LG. Diet and rheumatoid arthritis: A review of the literature. Semin Arthritis Rheum 2005;35:77-94.
20. Belch JJ, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidall anti-inflammatory drugs in patients with rheumatoid arthritis: A double blind placebo controlled study. Ann Rheum Dis 1988;47:96-104.
21. Davidson EM, Rae SA, Smith MJ. Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann Rheum Dis 1983;42:677-9.
22. Hernandez-Diaz S, Garcia-Rodriguez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med 2001; 110(9 Suppl. 3A):s20-7.